unknown by D Sanger
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Annals of General Hospital 
Psychiatry
Open AccessOral presentation
Atypical antipsychotics: similarities and differences at the synaptic 
level
D Sanger*
Address: Sanofi-Synthelabo Research, Bagneux, France, European Editor, Behavioural Pharmacology
* Corresponding author    
A number of so-called atypical, or new generation, antip-
sychotic drugs have been introduced into clinical practice
in recent years and provide significant advantages in terms
of tolerability and, under some circumstances, efficacy.
Like classical neuroleptics, all these newer drugs have
antagonist actions at dopamine D2 receptors in the brain.
The question has been raised, therefore, of the pharmaco-
logical mechanisms which are responsible for the atypical
profiles of the new drugs. In a number of cases, antago-
nism at the 5-HT2A subtype of serotonin receptors may be
involved. However, it is clear that this activity is neither
sufficient nor necessary to produce an atypical profile.
Recent findings with two of the newer drugs, amisulpride
and aripiprazole, have swung the spotlight back on to
dopamine. Amisulpride has high affinities for dopamine
D2 and D3 receptors without appreciable affinity for other
neurotransmitter receptors. In the clinic it shows efficacy
against positive and negative symptoms of schizophrenia
without producing Extrapyramidal Side effects. The
recently introduced antipsychotic, aripiprazole, also
seems to show good clinical efficacy with few adverse
effects. This drug also seems to act predominantly at
dopamine receptors although a role for serotonin has yet
to be completely ruled out. Explanations for the atypical
clinical profiles of certain selective dopaminergic antipsy-
chotics include selectivity for dopamine receptors in corti-
cal and limbic brain regions, preferential activity at
different dopamine receptors, partial agonist activity, and
fast dissociation from dopamine receptors.
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